Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025
recent articles
Nijmegen, the Netherlands, and Louvain-la-Neuve, Belgium — Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, and Telemis, a specialist in medical imaging and digital pathology, today announced a...
The latest from the Proscia blog: By Coleman Stavish | June 25, 2025 The Spring 2025 DICOM Working Group 26 (WG26) Whole Slide Imaging (WSI) Connectathon brought together key stakeholders shaping the future of digital pathology...
VISTA, California, June 25, 2025 – In a significant stride toward transforming the future of cancer diagnostics and research, Leica Biosystems proudly showcases its latest digital pathology portfolio solutions at booth #50 during the European...
Aiforia releases a new CE-IVD-marked clinical AI solution for breast cancer diagnostics Aiforia Technologies Plc, Press Release, June 24, 2025 at 9:00 a.m. EEST Aiforia Technologies Plc launches a new CE-IVD marked clinical AI solution...
Debiopharm taps ViewsML AI-driven platform to streamline biomarker detection in oncology research. VANCOUVER, BRITISH COLUMBIA, CANADA, June 17, 2025 /EINPresswire.com/ -- ViewsML, a techbio company specializing in AI-driven virtual...
Smart In Media, Fundación MD Anderson Cancer Center España, and Histofy announce a strategic alliance to promote the application of artificial intelligence to cancer diagnosis This strategic alliance will provide Histofy with secure and...
